PT90252A - Processo para a preparacao de um novo antibiotico polipeptidico com actividade anti-tumoral - Google Patents

Processo para a preparacao de um novo antibiotico polipeptidico com actividade anti-tumoral

Info

Publication number
PT90252A
PT90252A PT198990252A PT9025289A PT90252A PT 90252 A PT90252 A PT 90252A PT 198990252 A PT198990252 A PT 198990252A PT 9025289 A PT9025289 A PT 9025289A PT 90252 A PT90252 A PT 90252A
Authority
PT
Portugal
Prior art keywords
antibiotic
polypeptidic
preparation
new
tumor activity
Prior art date
Application number
PT198990252A
Other languages
English (en)
Other versions
PT90252B (pt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PT90252A publication Critical patent/PT90252A/pt
Publication of PT90252B publication Critical patent/PT90252B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
PT90252A 1988-04-12 1989-04-11 Processo para a preparacao de um novo antibiotico polipeptidico com actividade anti-tumoral PT90252B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18051988A 1988-04-12 1988-04-12
US07/323,001 US5001112A (en) 1988-04-12 1989-03-17 Antitumor antibiotic kedarcidin

Publications (2)

Publication Number Publication Date
PT90252A true PT90252A (pt) 1989-11-10
PT90252B PT90252B (pt) 1994-07-29

Family

ID=26876396

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90252A PT90252B (pt) 1988-04-12 1989-04-11 Processo para a preparacao de um novo antibiotico polipeptidico com actividade anti-tumoral

Country Status (24)

Country Link
US (1) US5001112A (pt)
EP (1) EP0337430B1 (pt)
JP (1) JP2850132B2 (pt)
KR (1) KR970010137B1 (pt)
CN (1) CN1034589C (pt)
AT (1) ATE101653T1 (pt)
AU (1) AU623641B2 (pt)
CA (1) CA1338262C (pt)
CY (1) CY1849A (pt)
DE (1) DE68913063T2 (pt)
DK (1) DK174751B1 (pt)
ES (1) ES2061760T3 (pt)
FI (1) FI93969C (pt)
HK (1) HK83195A (pt)
HU (1) HU201119B (pt)
IE (1) IE62912B1 (pt)
IL (1) IL89896A0 (pt)
MY (1) MY105842A (pt)
NO (1) NO174474C (pt)
NZ (1) NZ228672A (pt)
PL (1) PL161004B1 (pt)
PT (1) PT90252B (pt)
SG (1) SG30654G (pt)
YU (1) YU73989A (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143906A (en) * 1991-09-26 1992-09-01 Bristol-Myers Squibb Company Kedarcidin antitumor chromophore and pharmaceutical composition containing same
US20030180766A1 (en) * 2002-01-24 2003-09-25 Ecopia Biosciences, Inc. Method, system and knowledge repository for identifying a secondary metabolite from a microorganism
CA2777837C (en) * 2008-10-27 2017-07-11 Novartis Ag Purification method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS519837B2 (pt) * 1974-03-29 1976-03-30
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS6017206B2 (ja) * 1977-03-24 1985-05-01 浩 前田 ネオカルチノスタチン誘導体の製造法
JPS56113791A (en) * 1980-02-15 1981-09-07 Kaken Pharmaceut Co Ltd Novel antibiotic and its preparation
JPS57206693A (en) * 1981-06-10 1982-12-18 Ajinomoto Co Inc Protein an-7d
JPS59184135A (ja) * 1983-04-04 1984-10-19 Teijin Ltd グリセリンピログルタミン酸エステル類を含有する医薬品組成物

Also Published As

Publication number Publication date
KR900016469A (ko) 1990-11-13
PL161004B1 (pl) 1993-05-31
YU73989A (en) 1991-04-30
DK173589A (da) 1989-10-13
JP2850132B2 (ja) 1999-01-27
US5001112A (en) 1991-03-19
CA1338262C (en) 1996-04-23
NO174474C (no) 1998-06-09
JPH01317396A (ja) 1989-12-22
HU201119B (en) 1990-09-28
CN1037735A (zh) 1989-12-06
NO891462L (no) 1989-10-13
DE68913063T2 (de) 1994-06-09
EP0337430B1 (en) 1994-02-16
KR970010137B1 (ko) 1997-06-21
IE891157L (en) 1989-10-12
IE62912B1 (en) 1995-03-08
PL278782A1 (en) 1989-12-27
NZ228672A (en) 1990-07-26
EP0337430A2 (en) 1989-10-18
DK174751B1 (da) 2003-10-20
IL89896A0 (en) 1989-12-15
FI93969B (fi) 1995-03-15
ES2061760T3 (es) 1994-12-16
HK83195A (en) 1995-06-01
MY105842A (en) 1995-01-30
SG30654G (en) 1995-09-01
DE68913063D1 (de) 1994-03-24
EP0337430A3 (en) 1991-07-24
ATE101653T1 (de) 1994-03-15
FI93969C (fi) 1995-06-26
HUT50880A (en) 1990-03-28
FI891710L (fi) 1989-10-13
AU3272889A (en) 1989-10-19
CY1849A (en) 1996-03-08
PT90252B (pt) 1994-07-29
NO174474B (no) 1994-01-31
CN1034589C (zh) 1997-04-16
DK173589D0 (da) 1989-04-11
AU623641B2 (en) 1992-05-21
NO891462D0 (no) 1989-04-10
FI891710A0 (fi) 1989-04-11

Similar Documents

Publication Publication Date Title
AU3444989A (en) Biosynthetic osteogenic proteins and osteogenic devices containing them
DE3750056D1 (de) Polypeptid-Mutanten des menschlichen TNF und für diese Mutanten codierende DNS.
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
FI850744L (fi) Ny hjaertfoermak-peptid.
AU643959B2 (en) Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration
FI910025A0 (fi) Nya glugosisomeraser ii.
AU6661490A (en) Novel polypeptides, the DNA sequences allowing their expression, method of preparation, and utilization
AU6502986A (en) Human lysozyme
PT90252A (pt) Processo para a preparacao de um novo antibiotico polipeptidico com actividade anti-tumoral
DE58908428D1 (de) Sekretormutante von Escherichia coli.
ES2074046T3 (es) Procedimiento de construccion de una linea celular animal para la preparacion de beta-interferon humano.
IL76194A0 (en) 4,5-dihydro-4-oxo-2-((2-transphenylcyclopropyl)amino)-3-furancarboxylic acids and derivatives
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
ES2078229T3 (es) Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion.
ES2018734A6 (es) Procedimiento para la obtencion de un enzima proteolitico.
GR3006045T3 (pt)
AU1973388A (en) Improved process for the enzymatic preparation of l-2-amino-4-methylphosphinobutyric acid
AU5024490A (en) Method of recovering purified epi protein from a solution especially a fermentation solution
WO1990000179A3 (fr) Nouvelles proteins, adn les codant et leur usage
AU3810389A (en) Process for extracting and purifying epidermin
AU1786988A (en) Isoxazoles with nootropic activity
ES290997U (es) Cadena de pinzas de aguja a base de unas piezas soporte fi- jadas de manera desmontable en los eslabones de la cadena

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940105

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20090411